Saturday, January 31, 2026

ProGen’s PG-110 Targets Fat Loss Without Muscle Waste—Next-Gen Obesity Drug in Focus

ProGen will present non-clinical results of its obesity drug PG-110 at the ADA conference, targeting muscle preservation and weight loss.

Tensions Rise as Israel Targets Iran’s Nuclear Facilities

As Israel retaliates against Iran, the government...

Tag: Taipei

No posts to display

Top News

- Our Sponsors Ad -

Follow us